ARCHIVES

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

This article is from The Cancer Letter archive.

Vol. 34 No. 29 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Recruits Sosman To Lead Tumor Immunology.

January 18, 2002

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

Nine Saturation Program Planning Contracts Approved

May 9, 1975

President’s Cancer Panel Lists Recommendations For Improving Quality Of Cancer Care

April 9, 1999

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984